C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/505 (2006.01) C07D 209/00 (2006.01) C07D 239/00 (2006.01)
Patent
CA 2413651
Corticotropin releasing factor (CRF) antagonists of Formula (I) or (II) and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart- related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.
L'invention concerne des antagonistes de corticolibérine (CRF) représentés par la formule (I) ou (II) et leur utilisation dans le traitement de l'angoisse, de la dépression et d'autres troubles mentaux, neurologiques, ainsi que dans le traitement de maladies immunologiques, cardiovasculaires ou de cardiopathies et de l'hypersensibilité du côlon associée à l'agitation et au stress psychopathologiques.
Bristol-Myers Squibb Pharma Company
Gowling Lafleur Henderson Llp
LandOfFree
Pyrrolo¬3,4-d|pyrimidines as corticotropin releasing factor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolo¬3,4-d|pyrimidines as corticotropin releasing factor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolo¬3,4-d|pyrimidines as corticotropin releasing factor... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1616859